{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T10:48:18Z","timestamp":1773658098786,"version":"3.50.1"},"reference-count":29,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2001,12,24]],"date-time":"2001-12-24T00:00:00Z","timestamp":1009152000000},"content-version":"vor","delay-in-days":937,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Helicobacter"],"published-print":{"date-parts":[[1999,6]]},"abstract":"<jats:p><jats:bold>Background.<\/jats:bold> Bismuth triple therapy provides consistently good results in <jats:italic>Helicobacter pylori<\/jats:italic> eradication worldwide, whereas quadruple therapy using a combination of omeprazole and bismuth triple regimen has produced cure rates in excess of 90%. The prevalence of metronidazole\u2010resistant strains was 26.8% in our area. Colloidal bismuth pectin (CBP) is a new, lower\u2010priced bismuth salt made in China. The purpose of this study was to investigate the efficacy and safety of CBP triple and quadruple regimens in the treatment of <jats:italic>H. pylori<\/jats:italic>\u2013positive duodenal ulcer.<\/jats:p><jats:p><jats:bold>Materials and Methods.<\/jats:bold> In this prospective trial, 205 patients with <jats:italic>H. pylori<\/jats:italic>\u2013positive duodenal ulcer were allocated randomly to receive one of four regimens: metronidazole, 200 mg; amoxicillin, 250 mg; and colloidal bismuth subcitrate (CBS), 120 mg (group 1), or CBP, 100 mg qid (group 2) for 2 weeks, then continued CBS, 240 mg, or CBP, 200 mg bid for a further 2 weeks. A quadruple regimen using a combination of omeprazole, 20 mg bid, and CBS triple therapy (group 3) or CBP triple therapy (group 4), respectively, was given to patients for 1 week, followed by omeprazole, 20 mg once daily for a further 3 weeks. Further endoscopy was performed at least 4 weeks after cessation of the treatment. <jats:italic>H. pylori<\/jats:italic> status was determined by histology, a <jats:sup>14<\/jats:sup>C urea breath test, and a urease test.<\/jats:p><jats:p><jats:bold>Results.<\/jats:bold> The per\u2010protocol <jats:italic>H. pylori<\/jats:italic> cure rates were 85% (22 of 26 patients), 90% (35 of 39), 96% (46 of 48), and 95% (75 of 79) for groups 1 through 4. In the intention\u2010to\u2010treat analysis, cure rates were 79% (22 of 28), 83% (35 of 42), 90% (46 of 51), and 89% (75 of 84), respectively. The cure rates of quadruple therapy were higher than those of triple therapy; an 8.2% difference was not statistically significant (95% confidence interval [CI], 2.3\u201318.7%). The ulcer\u2010healing rates were 88%, 87%, 98%, and 97%, respectively, for groups 1 through 4. The ulcer pain was relieved more rapidly in quadruple\u2010 than in triple\u2010therapy regimens. Two patients discontinued treatment prematurely owing to drug\u2010related side effects.<\/jats:p><jats:p><jats:bold>Conclusion.<\/jats:bold> One\u2010week quadruple therapy is highly effective and safe in <jats:italic>H. pylori<\/jats:italic> eradication in Chinese patients. CBP is as effective as CBS.<\/jats:p>","DOI":"10.1046\/j.1523-5378.1999.98281.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T23:21:18Z","timestamp":1047424878000},"page":"128-134","source":"Crossref","is-referenced-by-count":17,"title":["Colloidal Bismuth Pectin: An Alternative to Bismuth Subcitrate for the Treatment of <i>Helicobacter pylori<\/i>\u2013 Positive Duodenal Ulcer"],"prefix":"10.1111","volume":"4","author":[{"given":"Yuqiang","family":"Nie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuyuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huisheng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weihong","family":"Sha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoujun","family":"Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qinglin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2002,4,19]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199302043280512"},{"key":"e_1_2_6_3_2","doi-asserted-by":"crossref","unstructured":"National Institutes of Health Consensus Conference.Helicobacter pyloriin peptic ulcer disease. JAMA 1994;272:65\u20139.","DOI":"10.1001\/jama.272.1.65"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-5378.1996.tb00003.x"},{"key":"e_1_2_6_5_2","first-page":"192","article-title":"Helicobacter pylori eradication with low\u2010dose amoxicillin\u2010metronidazole\u2013colloidal bismuth subcitrate triple therapy: A nation\u2010wide cooperative clinical study in China.","volume":"16","author":"Liu XG","year":"1996","journal-title":"Chin J Dig"},{"key":"e_1_2_6_6_2","first-page":"34","article-title":"The summary of studies on colloidal bismuth pectin in vitro and in vivo.","volume":"2","author":"Yu XM","year":"1993","journal-title":"China New Drugs J"},{"key":"e_1_2_6_7_2","first-page":"6","article-title":"A multiple\u2010center study on the eradication of HP with triple therapy of colloidal bismuth pectin.","volume":"13","author":"Zhou LY","year":"1997","journal-title":"China J Clin Pharmacol"},{"key":"e_1_2_6_8_2","first-page":"742","article-title":"Oxyntic and antral gastritis in the People\u2019s Republic of China: Diagnosis and relationship to Helicobacter pylori.","volume":"87","author":"Hu PJ","year":"1992","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(94)91111-8"},{"key":"e_1_2_6_10_2","first-page":"1158","article-title":"Simple noninvasive method to test efficacy of drugs in the eradication of Helicobacter pylori infection: The example of combined bismuth subsalicylate and nitrofurantoin.","volume":"89","author":"Graham DY","year":"1991","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199302043280503"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.1998.216_a.x"},{"key":"e_1_2_6_13_2","first-page":"1395","article-title":"Low H. pylori reinfection rate after triple therapy in Chilean duodenal ulcer patients.","volume":"91","author":"Figueroa G","year":"1996","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1996.729121000.x"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-5378.1996.tb00028.x"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(94)91460-5"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(95)92962-2"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.37.4.477"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365548909039972"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1097\/00042737-199309000-00003"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.1995.tb00349.x"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1097\/00042737-199409000-00004"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.1995.tb00374.x"},{"issue":"1","key":"e_1_2_6_24_2","first-page":"S17","article-title":"Management of Helicobacter pylori\u2013related disorders.","volume":"9","author":"Misiewicz JJ","year":"1997","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"e_1_2_6_25_2","first-page":"19","article-title":"H. pylori treated with combination of tripotassium dicitrato and metronidazole: Efficacy of different treatment regimens and some observations on the emergence of metronidazole resistance.","volume":"3","author":"Bell GD","year":"1991","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.305.6852.502"},{"key":"e_1_2_6_27_2","first-page":"25","article-title":"Efficacy and side effects of low\u2010dosage triple therapy for the eradication of Helicobacter pylori in duodenal ulcer patients.","volume":"15","author":"Hu PJ","year":"1995","journal-title":"Chin J Dig"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-5378.1996.tb00009.x"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1998.00266.x"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365529509093298"}],"container-title":["Helicobacter"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1523-5378.1999.98281.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1523-5378.1999.98281.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1046\/j.1523-5378.1999.98281.x","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1523-5378.1999.98281.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T03:33:50Z","timestamp":1694403230000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1523-5378.1999.98281.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,6]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1999,6]]}},"alternative-id":["10.1046\/j.1523-5378.1999.98281.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1523-5378.1999.98281.x","archive":["Portico"],"relation":{},"ISSN":["1083-4389","1523-5378"],"issn-type":[{"value":"1083-4389","type":"print"},{"value":"1523-5378","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999,6]]}}}